STERIS plc's results for fiscal Q2 2027 (ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-11-04. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $1,589 million (+8.8% vs a year earlier) |
| Diluted EPS (GAAP) | $2.19 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $2.94 |
| Full-year guidance | Raised |
Guidance
STERIS raised fiscal 2027 adjusted EPS outlook to $11.35–$11.55 from $11.10–$11.30, including tariff refunds; revenue growth outlook unchanged at 7–8%.
Why this label: Adjusted EPS $11.35–$11.55, 'an increase from prior expectations of $11.10 to $11.30'; revenue growth outlook unchanged.
| Metric | Period | New | Prior (as stated in the release) |
|---|---|---|---|
| adjusted EPS per diluted share | FY2027 | $11.35–11.55 | $11.10–11.30 |
| as reported revenue growth | FY2027 | 7–8% | not stated |
| constant currency organic revenue growth | FY2027 | 6–7% | not stated |
| segment CC organic revenue growth: Applied Sterilization Technologies | FY2027 | 6–7% | 7–8% |
| segment CC organic revenue growth: Life Sciences | FY2027 | 9–10% | 6–7% |
| segment CC organic revenue growth: Healthcare | FY2027 | 6–7% | 6–7% |
From the release
Revenue: "Revenues · $ · 1,588.6 · $ · 1,460.3"
Earnings per share: "As reported, net income for the second quarter was $213.7 million, or $2.19 per diluted share, compared with net income of $191.9 million, or $1.94 per diluted share, in the second quarter of fiscal 2026."
adjusted EPS per diluted share: "Adjusted earnings per diluted share are now anticipated to be in the range of $11.35 to $11.55, an increase from prior expectations of $11.10 to $11.30."
as reported revenue growth: "Expectations for consolidated revenue growth are unchanged and include as reported revenue growth of 7-8% and constant currency organic revenue growth of 6-7%."
constant currency organic revenue growth: "Expectations for consolidated revenue growth are unchanged and include as reported revenue growth of 7-8% and constant currency organic revenue growth of 6-7%."
Quotes are copied from the filing; in table rows, cell borders are shown as “·”.
Key fact: Adjusted EPS outlook raised to $11.35–$11.55 from $11.10–$11.30, including tariff refunds.
Source
STERIS plc earnings release (SEC filing), accession 0001628280-26-070220, filed 2026-11-04.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.